These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22959526)

  • 1. Identification of novel α7 nicotinic receptor ligands by in silico screening against the crystal structure of a chimeric α7 receptor ligand binding domain.
    Akdemir A; Edink E; Thompson AJ; Lummis SC; Kooistra AJ; de Graaf C; de Esch IJ
    Bioorg Med Chem; 2012 Oct; 20(19):5992-6002. PubMed ID: 22959526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholine binding protein (AChBP) as template for hierarchical in silico screening procedures to identify structurally novel ligands for the nicotinic receptors.
    Akdemir A; Rucktooa P; Jongejan A; Elk Rv; Bertrand S; Sixma TK; Bertrand D; Smit AB; Leurs R; de Graaf C; de Esch IJ
    Bioorg Med Chem; 2011 Oct; 19(20):6107-19. PubMed ID: 21920761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of acetylcholine binding protein in the search for novel alpha7 nicotinic receptor ligands. In silico docking, pharmacological screening, and X-ray analysis.
    Ulens C; Akdemir A; Jongejan A; van Elk R; Bertrand S; Perrakis A; Leurs R; Smit AB; Sixma TK; Bertrand D; de Esch IJ
    J Med Chem; 2009 Apr; 52(8):2372-83. PubMed ID: 19331415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and expression of human alpha7 nicotinic acetylcholine receptor extracellular domain mutants with enhanced solubility and ligand-binding properties.
    Zouridakis M; Zisimopoulou P; Eliopoulos E; Poulas K; Tzartos SJ
    Biochim Biophys Acta; 2009 Feb; 1794(2):355-66. PubMed ID: 19059502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.
    Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR
    J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple interaction regions in the orthosteric ligand binding domain of the α7 neuronal nicotinic acetylcholine receptor.
    Xiao Y; Hammond PS; Mazurov AA; Yohannes D
    J Chem Inf Model; 2012 Nov; 52(11):3064-73. PubMed ID: 23092444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docking studies of benzylidene anabaseine interactions with α7 nicotinic acetylcholine receptor (nAChR) and acetylcholine binding proteins (AChBPs): application to the design of related α7 selective ligands.
    Kombo DC; Mazurov A; Tallapragada K; Hammond PS; Chewning J; Hauser TA; Vasquez-Valdivieso M; Yohannes D; Talley TT; Taylor P; Caldwell WS
    Eur J Med Chem; 2011 Nov; 46(11):5625-35. PubMed ID: 21986237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomolecular recognition of antagonists by α7 nicotinic acetylcholine receptor: Antagonistic mechanism and structure-activity relationships studies.
    Peng W; Ding F
    Eur J Pharm Sci; 2015 Aug; 76():119-32. PubMed ID: 25963024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel alpha7 nicotinic receptor antagonists.
    Peng Y; Zhang Q; Snyder GL; Zhu H; Yao W; Tomesch J; Papke RL; O'Callaghan JP; Welsh WJ; Wennogle LP
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4825-30. PubMed ID: 20638843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of selective agonists for the α7 nicotinic acetylcholine receptor with in situ click-chemistry on acetylcholine-binding protein templates.
    Yamauchi JG; Gomez K; Grimster N; Dufouil M; Nemecz A; Fotsing JR; Ho KY; Talley TT; Sharpless KB; Fokin VV; Taylor P
    Mol Pharmacol; 2012 Oct; 82(4):687-99. PubMed ID: 22784805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification by virtual screening and functional characterisation of novel positive and negative allosteric modulators of the α7 nicotinic acetylcholine receptor.
    Smelt CLC; Sanders VR; Newcombe J; Burt RP; Sheppard TD; Topf M; Millar NS
    Neuropharmacology; 2018 Sep; 139():194-204. PubMed ID: 30009834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations.
    Hansen SB; Sulzenbacher G; Huxford T; Marchot P; Taylor P; Bourne Y
    EMBO J; 2005 Oct; 24(20):3635-46. PubMed ID: 16193063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2.7 A structure of AChBP, homologue of the ligand-binding domain of the nicotinic acetylcholine receptor.
    Brejc K; van Dijk WJ; Smit AB; Sixma TK
    Novartis Found Symp; 2002; 245():22-9; discussion 29-32, 165-8. PubMed ID: 12027010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro binding characteristics of [3H]AZ11637326, a novel alpha7-selective neuronal nicotinic receptor agonist radioligand.
    Gordon JC; Phillips E; Gurley DA; Heys JR; Lazor LA; Barthlow HG; Mallamaci MA; Keith RA
    Eur J Pharmacol; 2010 Oct; 645(1-3):63-9. PubMed ID: 20674564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric structural motions of the homomeric alpha7 nicotinic receptor ligand binding domain revealed by molecular dynamics simulation.
    Henchman RH; Wang HL; Sine SM; Taylor P; McCammon JA
    Biophys J; 2003 Nov; 85(5):3007-18. PubMed ID: 14581202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the structural determinants required for high-affinity binding of chiral cyclopropane-containing ligands to α4β2-nicotinic acetylcholine receptors: an integrated approach to behaviorally active nicotinic ligands.
    Zhang HK; Eaton JB; Yu LF; Nys M; Mazzolari A; van Elk R; Smit AB; Alexandrov V; Hanania T; Sabath E; Fedolak A; Brunner D; Lukas RJ; Vistoli G; Ulens C; Kozikowski AP
    J Med Chem; 2012 Sep; 55(18):8028-37. PubMed ID: 22928944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An allosteric binding site of the α7 nicotinic acetylcholine receptor revealed in a humanized acetylcholine-binding protein.
    Delbart F; Brams M; Gruss F; Noppen S; Peigneur S; Boland S; Chaltin P; Brandao-Neto J; von Delft F; Touw WG; Joosten RP; Liekens S; Tytgat J; Ulens C
    J Biol Chem; 2018 Feb; 293(7):2534-2545. PubMed ID: 29237730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery, synthesis, biological evaluation and structure-based optimization of novel piperidine derivatives as acetylcholine-binding protein ligands.
    Shen J; Yang XC; Yu MC; Xiao L; Zhang XJ; Sun HJ; Chen H; Pan GX; Yan YR; Wang SC; Li W; Zhou L; Xie Q; Yu LQ; Wang YH; Shao LM
    Acta Pharmacol Sin; 2017 Jan; 38(1):146-155. PubMed ID: 27917874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential pharmacological activity of JN403 between α7 and muscle nicotinic acetylcholine receptors.
    Arias HR; De Rosa MJ; Bergé I; Feuerbach D; Bouzat C
    Biochemistry; 2013 Nov; 52(47):8480-8. PubMed ID: 24164482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble, oligomeric, and ligand-binding extracellular domain of the human alpha7 acetylcholine receptor expressed in yeast: replacement of the hydrophobic cysteine loop by the hydrophilic loop of the ACh-binding protein enhances protein solubility.
    Avramopoulou V; Mamalaki A; Tzartos SJ
    J Biol Chem; 2004 Sep; 279(37):38287-93. PubMed ID: 15226316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.